Department of Pediatrics, Washington University School of Medicine in St. Louis, Campus Box 8116, 660 South Euclid Avenue, St Louis, MO 63110, USA.
Department of Pediatrics, Washington University School of Medicine in St. Louis, Campus Box 8116, 660 South Euclid Avenue, St Louis, MO 63110, USA.
Immunol Allergy Clin North Am. 2019 May;39(2):177-190. doi: 10.1016/j.iac.2018.12.003.
The management of asthma in the preschool population is challenging because disease phenotypes are heterogeneous and evolving. Available therapies aimed at preventing persistent symptoms and recurrent exacerbations include inhaled corticosteroids and leukotriene receptor antagonists; episodic use of inhaled corticosteroids and azithromycin may result in a decrease in exacerbations among children with intermittent disease. This article reviews an approach using patient characteristics for selecting initial treatment approaches based on disease phenotype, such as symptom patterns or evidence of atopic markers. Evidence for and against the use of oral corticosteroids during acute episodes and barriers to adherence and effective treatment are discussed.
学龄前人群哮喘的管理颇具挑战,因为疾病表型具有异质性且处于不断变化中。现有的旨在预防持续性症状和反复恶化的治疗方法包括吸入皮质类固醇和白三烯受体拮抗剂;间歇性疾病患儿间断使用吸入皮质类固醇和阿奇霉素可能会减少恶化次数。本文通过患者特征综述了一种基于疾病表型(如症状模式或特应性标志物证据)选择初始治疗方法的方法。本文还讨论了急性发作期使用口服皮质类固醇的依据和反对依据以及治疗顺应性和有效性的障碍。